Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research, Inc. is a Canadian specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units: the Topical Products and Technology (TPT) Group (formerly the Pain Group) and the Immunology Group.
Price: $4.48 | Change: +$0.24 | %Change: +5.66%
Volume: 145,175 | Day High/Low: 4.50/4.24 | 52 Week High/Low: 5.73/1.58
View modes: 
3.5 stars

RE:RE:RE:New Seeking Alpha Article

Rock, do your parents know that you are on the computer again? LOL, more like he has been spitting out his meds after his mom turns the lights out.  rate and reply
3.5 stars

RE:RE:New Seeking Alpha Article

"Thank you to both of the Lil Folk?" Rock, do your parents know that you are on the computer again?  rate and reply
2.5 stars

Seeking Alpha says Strong Buy .. target $7.50

Nuvo Research Offers Low-Risk With Big Upside May. 5, 2014 9:31 AM ET  |  2 comments |  About: NRIFF, Includes: MNK Disclosure: I have no positions in any...read more
2.5 stars

RE:New Seeking Alpha Article

Thank you to both of the Lil Folk. C99, I am very impressed with your investing success. In the absence of your NRI investment, you are deep in the hole for 2014 to date. Do you pik by random...read more
5 stars

New Seeking Alpha Article

[url=http://http://seekingalpha.com/article/2190673-nuvo-research-offers-low-risk-with-big-upside?isDirectRoadblock=false&uprof=45]Nuvo Research Low Risk Investment[/url] It is interesting when an...read more
5 stars

RE:RE:RE:RE:RE:RE:RE:Q1 Results

Thanks, 99. Will have to wait for the year end financial report to see what gross profit margins were for 2013. If you are right about how small the initial order for P2 was, the implication is that...read more
2.5 stars

little folk doing it again

Time ET Ex Price Change Volume Buyer Seller Markers 09:47:39 T 3.25 -0.12 100 1 Anonymous 79 CIBC 09:30:00 T 3.25 -0.12 70 84 Ind Trading 80 National Bank 09:30:00 T 3.33 -0.04 200 79 CIBC 80...read more
2.5 stars

$100 + million litigation suit on schedule

Nuvo and Mallinckrodt have agreed to a joint discovery schedule in which document discovery is to be substantially completed by June 2014 and all fact discovery is to be completed by December 2014...read more
5 stars

RE:RE:RE:RE:RE:RE:Q1 Results

There are the retail sales that MNK make and then there are the wholesale shipments that Nuvo makes which includes inventory. So while there were only a small number of scripts for Pennsaid 2% and...read more
5 stars

RE:RE:RE:RE:RE:Q1 Results

let me edit that last sentence: paddypower wrote: Did anyone note the sentence '' COGS increased due to  due to increased Pennsaid (P1) and Pennsaid 2% (P2) product sales.  '' How can that be...read more
3 stars

RE:RE:RE:RE:Q1 Results

Rocky Racoon: you do bring a bit of levity to the thread. So ta for that. Any chance you'll disclose your NRI holdings, not so much out of curiouslity, but just so we can judge what is '' small'' to...read more
5 stars

RE:RE:RE:RE:Q1 Results

Good question to ask, just how profitable is P2? I will continue to hold, as long as I can expect growth in all sources of revenue to occur, provided gross margins are maintanied. The NR for Q1...read more
5 stars

RE:RE:RE:Q1 Results

While the quarter reaks I can't say 6 weeks in  that P2 is a disappointment, lets give it at least two quarters to make that judgement. From what I gathered reading the CafeP website P2 is not covered...read more
2.5 stars

RE:RE:RE:Q1 Results

Little folk very angry that cash burn so low and cash build so robust. Expect them to dump more of their shares today. If they dump all (69 shares), it could be a rocky start. Lol  rate and reply
5 stars

RE:RE:Q1 Results

''Nice ramp up'' - yeah, nice ramp down, too.  It's nice to be nice, isnt it, Rocksinhead?....What reality do you subscribe to - Rocky 9 ? Q1 2013 43,000 P1 Pennsaid. 2014 24,000 P1 + 6,000 P2...read more
4.5 stars

RE:RE:Q1 Results

actually no news at all really, -sales income down -scripts down -P2% "launch" is a dud, like its predecessor launches everywhere -income from Zars purchase is missing in action -loans up -severe...read more
2 stars

RE:Q1 Results

Very solid quarter in transition to P2 sales ramp up.  Cash burn rate reduced to $900,000. NRI ended the quarter with a whopping $14.2 million in cash plus another $2 million very soon once forced...read more
4 stars

Q1 Results

Uninspiring! Thanks Dan and John for another losing quarter under your leadership. Nuvo Research loses $2.74-million in Q1 2014 Ticker Symbol: C:NRI Nuvo Research loses $2.74-million in Q1 2014 Nuvo...read more
4 stars

RE:Interesting battle

Sorry if you can't handle the truth, Rock. If you are going to post then try to make the effort to be accurate. Spin it all you want but don't bullsh*t people with half-truths or speculation based on...read more
1.5 stars

Interesting battle

Between the forced and the voluntary. C99 just dont waste our time with your transparent postings here. We are sick of the whinings of you Little Folk. Drop dead or better still, get a real life.  rate and reply